ID: h-3a8f13ac
Hypothesis

Senescence-Associated Epigenetic Phenotype (SEP)

The Senescence-Associated Epigenetic Phenotype (SEP) is hypothesized to contribute to neurodegeneration, potentially acting as a driver of disease progression.
🧬 Senescence-Associated Epigenetic Phenotype🩺 neurodegeneration🎯 Composite 62%💱 $0.56▼9.9%proposed
EvidencePending (0%)📖 5 cit🗣 1 debates 5 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.70 (15%) Evidence 0.65 (15%) Novelty 0.50 (12%) Feasibility 0.75 (12%) Impact 0.70 (12%) Druggability 0.70 (10%) Safety 0.45 (8%) Competition 0.60 (6%) Data Avail. 0.65 (5%) Reproducible 0.60 (5%) KG Connect 0.50 (8%) 0.620 composite

🧪 Overview

The Senescence-Associated Epigenetic Phenotype (SEP) is hypothesized to contribute to neurodegeneration, potentially acting as a driver of disease progression. However, recent reappraisals of accelerated aging in neurodegeneration caution that aging signatures may be correlative and conceptually overextended rather than causal drivers (PMID:37887295). In addition, cellular models of aging and senescence exhibit substantial model-dependence, limiting direct inference from a senescence‑associated epigenetic phenotype to human neurodegeneration (PMID:40862757).

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Senescence-Associated Epigenetic Phenotype<br/>Hypothesis Target"]
    B["Senescence<br/>Cited Mechanism"]
    C["Cellular Response<br/>Stress or Clearance Change"]
    D["Neural Circuit Effect<br/>Synapse/Glia Vulnerability"]
    E["Neurodegeneration<br/>Disease-Relevant Outcome"]
    A --> B
    B --> C
    C --> D
    D --> E
    style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style B fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix5 supports2 contradicts
Supports
[An antipsychotic without dopamine receptor blockade?].
Tijdschr Psychiatr2021PMID:34851520medium
Supports
DNA methylation signatures as biomarkers of socioeconomic position.
Environ Epigenet2023PMID:36694711medium
Supports
Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models.
Nat Commun2017PMID:29162828medium
Supports
Life-course socioeconomic position and the gut microbiome in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Gut Microbes2025PMID:40102030medium
Supports
The role of health-based food choice motives in explaining the relationship between lower socioeconomic position and higher BMI in UK and US adults.
Int J Obes (Lond)2022PMID:35864310medium
Contradicts
A reappraisal of accelerated aging in neurodegeneration warns that aging signatures may be correlative and conceptually overextended rather than causal drivers.
Cells2023PMID:37887295medium
Contradicts
Cellular aging and senescence models have substantial model-dependence, limiting direct inference from a senescence-associated epigenetic phenotype to human neurodegeneration.
Cells2025PMID:40862757medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — SENESCENCE-ASSOCIATED

No curated PDB or AlphaFold mapping for SENESCENCE-ASSOCIATED yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for Senescence-Associated Epigenetic Phenotype →

No DepMap CRISPR Chronos data found for Senescence-Associated Epigenetic Phenotype.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.9%
Volatility
Low
0.0057
Events (7d)
3
Price History
▼9.9%

💾 Resource Usage

LLM Tokens
36,950
$0.1109
Total Cost
$0.1109

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF senolytic therapy (dasatinib 100mg + quercetin 1000mg, daily for 3 consecutive days per month for 12 months) is administered to early-stage Alzheimer's disease patients, THEN measurable reduction i≥30% reduction in composite SASP score and epigenetic age deceleration of ≥1 year compared to placebo group— no observation —pending0.65
IF human iPSC-derived cortical neurons are subjected to radiation-induced senescence (10 Gy gamma irradiation) and subsequently treated with epigenetic editing (HDAC inhibitor valproic acid 1mM for 7 ≥20% reversion of radiation-induced DMPs in senescence pathways after HDAC inhibition— no observation —pending0.55
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF senolytic therapy (dasatinib 100mg + quercetin 1000mg, daily for 3 consecutive days per month for 12 months) is administered to early-stage Alzheimer's disease patients, THEN measurable reduction in plasma SASP factors (IL-6, IL-8, TNF-α) by ≥30% and deceleration of epigenetic age acceleration (H
Predicted outcome: ≥30% reduction in composite SASP score and epigenetic age deceleration of ≥1 year compared to placebo group
Falsification: No significant difference in SASP factor levels or epigenetic age acceleration between senolytic and placebo groups (p > 0.05)
pendingconf 55%
IF human iPSC-derived cortical neurons are subjected to radiation-induced senescence (10 Gy gamma irradiation) and subsequently treated with epigenetic editing (HDAC inhibitor valproic acid 1mM for 7 days), THEN genome-wide DNA methylation profiling should reveal reversion of ≥20% of differentially
Predicted outcome: ≥20% reversion of radiation-induced DMPs in senescence pathways after HDAC inhibition
Falsification: Fewer than 10% of DMPs revert toward baseline, or reversion occurs in non-senescence pathways only, indicating off-target effects rather than SEP reversal
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.